Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel by Borry, Pascal et al.
   1Borry P, et al. Br J Sports Med 2018;0:1–4. doi:10.1136/bjsports-2017-098299
Geolocalisation of athletes for out-of-competition 
drug testing: ethical considerations. Position 
statement by the WADA Ethics Panel
Pascal Borry,1 Timothy Caulfield,2 Xavier Estivill,3 Sigmund Loland,4 
Michael McNamee,5 Bartha Maria Knoppers,6 on behalf of the WADA Ethics Panel 
Consensus statement
To cite: Borry P, 
Caulfield T, Estivill X, et al. 
Br J Sports Med Epub ahead 
of print: [please include Day 
Month Year]. doi:10.1136/
bjsports-2017-098299
1Department of Public Health 
and Primary Care, University of 
Leuven, Leuven, Belgium
2Faculty of Law and School 
of Public Health, University of 
Alberta, Edmonton, Canada
3Genetics Program, Sidra 
Medical and Research Centre, 
Doha, Qatar
4Department of Cultural and 
Social Studies, Norwegian 
School of Sport Sciences, Oslo, 
Norway
5College of Engineering, 
Swansea University, Swansea, 
UK
6Centre of Genomics and Policy, 
McGill University, Montreal, 
Canada
Correspondence to
Professor Pascal Borry, Centre 
for Biomedical Ethics and Law, 
Leuven 3000, Belgium;  
 pascal. borry@ med. kuleuven. be
Accepted 5 February 2018
AbsTrACT
Through the widespread availability of location-
identifying devices, geolocalisation could potentially be 
used to place athletes during out-of-competition testing. 
In light of this debate, the WADA Ethics Panel formulated 
the following questions: (1) should WADA and/or other 
sponsors consider funding such geolocalisation research 
projects?, (2) if successful, could they be proposed to 
athletes as a complementary device to Anti-Doping 
Administration and Management System to help 
geolocalisation and reduce the risk of missed tests? and 
(3) should such devices be offered on a voluntary basis, 
or is it conceivable that they would be made mandatory 
for all athletes in registered testing pools? In this 
position paper, the WADA Ethics Panel concludes that 
the use of geolocalisation could be useful in a research 
setting with the goal of understanding associations 
between genotype, phenotype and environment; 
however, it recognises that the use of geolocalisation 
as part of or as replacement of whereabouts rules is 
replete with ethical concerns. While benefits remain 
largely hypothetical and minimal, the potential invasion 
of privacy and the data security threats are real. 
Considering the impact on privacy, data security issues, 
the societal ramifications of offering such services and 
various pragmatic considerations, the WADA Ethics Panel 
concludes that at this time, the use of geolocalisation 
should neither be mandated as a tool for disclosing 
whereabouts nor implemented on a voluntary basis.
Some prohibited substances are detectable only 
for a limited period of time in an athlete’s body 
while still maintaining a performance-enhancing 
effect. Designed to protect the integrity of sport, 
out-of-competition doping controls increase the 
efficiency of the antidoping programmes. One 
approach, the ‘whereabouts system,’ was intro-
duced as a mechanism to enable out-of-competi-
tion testing. Indeed, the only way to perform such 
testing is by knowing where athletes are at a partic-
ular time. Its efficiency depends on the ability to 
be able to test athletes at times at which cheaters 
are most likely to use prohibited substances and 
methods. Athletes must not be aware such testing 
will occur.
The whereabouts system has been heavily crit-
icised in the past for various reasons, including 
its surveillance character,1 its infringement of 
privacy,2 3 its high costs and the burden it places 
on athletes.4 Nevertheless, the system received 
sufficient support, and also recently, the European 
Court of Human Rights concluded in its ruling of 
18 January 2018 (Affaire féderation nationale des 
associations et syndicats sportifs et autres c. France) 
that the whereabouts system can be defended on 
public interest grounds. The Court rules that restric-
tions imposed on the right to respect for private and 
family life (article 8) can be justified considering 
that the reduction or removal of whereabouts obli-
gations would lead to an increase in the dangers of 
doping for the health of sports professionals and of 
all those who practise sports and would be at odds 
with the European and international consensus on 
the need for unannounced testing as part of doping 
control.
Although athletes themselves often see the 
whereabouts system as a ‘necessary evil’,5 they have 
also indicated that the system interfered negatively 
in their everyday life.4 6 Recently, several athletes 
have publicly declared that they would prefer to be 
‘geolocalised’–that is, to have their location iden-
tified automatically by a wearable or implantable 
technology– rather than having to regularly fill in 
and update their whereabouts information into 
WADA’s Anti-Doping Administration and Manage-
ment System (ADAMS) software platform.6 At 
various occasions, proposals have been made to 
radically change the current antidoping procedures, 
and the use of Global Position System (GPS) tech-
nology to track athletes has been put forward as a 
new tool.
As part of their call for research programmes, 
the IOC and WADA have received several project 
proposals aiming at developing devices or smart-
phone applications that would facilitate the geolo-
calisation of athletes. To date, the IOC and WADA 
have refrained from sponsoring such studies because 
of concerns with the ethical aspects that such tools 
could potentially generate. In addition, such tools 
are often misperceived as being replacements for 
ADAMS, when in reality whereabouts information 
for ADAMS would still be needed since instant 
geolocalisation would not enable testing authori-
ties to plan their missions sufficiently ahead of the 
desired collection time.
The WADA Ethics Panel discussed this topic 
during its meeting in Montreal on 7–8 March 2016 
and in Lausanne on 12 March 2017. The WADA 
Athlete Committee was consulted in the prepara-
tion of this position paper. The WADA Ethics Panel 
is a designated panel assembled by the WADA Exec-
utive Office. Its purpose is to provide expert ethical 
opinion on ethical issues that may arise in the fight 
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against doping in sport and to develop and/or recommend ethi-
cally sound policy or suggestions to WADA management. Views 
of the WADA Ethics Panel do not necessarily represent the offi-
cial opinion of WADA management.
WhAT Are The CurrenT WhereAbouTs requiremenTs?
Whereabouts rules are part of the International Standard for 
Testing and Investigation (ISTI). The ISTI is mandatory for 
Anti-Doping Organizations (ADOs)–including International 
Sport Federations (IFs), National Anti-Doping Organizations 
(NADOs) and Major Games Organizers–that have adopted 
the World Anti-Doping Code (the document harmonising anti-
doping rules in all sports). Whereabouts information is provided 
by a limited number of top elite athletes to the IF or NADO that 
include them in their respective registered testing pool (RTP) as 
part of these top elite athletes’ antidoping responsibilities.
The requirement for top-level athletes included in the RTP 
of either their IF or NADO is that they need to specify 1 hour 
each day (between 6:00 hours and 23:00 hours) during which 
they assure they can be located at a specified location for testing. 
If an ADO would have serious and specific suspicion that the 
athlete may be engaged in doping, the ISTI can also have athletes 
tested outside those hours. Therefore, athletes are also required 
to provide for each day during the following quarter the full 
address of the place where the athlete will be staying overnight.
Athletes can update their 60 min time slot and their where-
abouts at any time. If they miss a test, they have the opportu-
nity of providing a reason justifying their absence. If this excuse 
is accepted by the relevant antidoping organisation, then the 
missed test is not part of any record and does not count as one 
of three missed tests within 12 months that could give rise to a 
sanction by the relevant ADO. Full details on the whereabouts 
system can be found in part I.3. of the ISTI.
The developmenT of loCATion-bAsed serviCes
The use of technology that enables geolocalisation of individuals 
is growing rapidly and has become commonplace in our society. 
Indeed, GPS devices are commonly used for commercial, profes-
sional and personal use. Moreover, location-based services are 
integrated in most telecommunications and mobile computing 
platforms, such as smartphones and laptops. Users often reveal 
their location to third-party applications, without realising that 
information about their location will be used or kept after having 
used this service.7
WhAT Are The poTenTiAl AdvAnTAges of 
geoloCAlisATion for AThleTes?
Some athletes have suggested that the use of GPS tracking 
in athletes’ phones, the use of tracking bracelets or, even, 
implantable devices could be used to provide continuous infor-
mation about their location and whereabouts.8 In this way, some 
have argued that the likelihood of missing an out-of-competition 
test could be drastically diminished. Consider situations where 
athletes arrive late in the designated 60 min time slot due to 
heavy traffic or in situations where athletes don’t have access to 
internet. As one athlete reported:
I feel it is a lot of bother to keep track of the time… for instance, if 
you are on holiday and don’t know what you would like to do the 
following day, you have a problem!! Especially if there is no access 
to the internet. It would be a relief to have access to some kind of 
gps/tracking device or something like that that you could take with 
you instead of reporting whereabouts.
[Quoted in 4] Moreover, some have argued that the administra-
tive burdens of filling in and updating the whereabouts could 
be reduced.4 In addition, it could provide antidoping officials 
with supplementary tools to locate the athletes and perform 
out-of-competition controls. Geolocalisation data could also 
help interpret better the data integrated in the Athlete Biolog-
ical Passport (ABP). The ABP has been introduced to monitor 
selected variables (biomarkers) over time that indirectly reveal 
the effect of doping, as opposed to the traditional direct detec-
tion of doping by analytical doping controls. This includes, 
for example, haematocrit, haemoglobin and red cell counts. 
Although several factors are known to affect the results of these 
markers (such as age, gender, sport discipline or ethnic origin), 
altitude exposure is not taken into account in a standardised way 
in ABP.9 As altitude is an important variable, it is important to 
integrate information about altitude in the calculation of ABP.9 10 
Localisation information about the athletes, and therefore alti-
tude information, could inform the calculation of ABP values. 
Moreover, from a broader scientific perspective, the availability 
of this information has potential value, in understanding better 
the patterns and relationships between nature (genotype), 
nurture (phenotype) and exposure (environment), including 
geographical data.11 It could, for example, provide a better 
understanding of the exact effect of altitude exposure on the 
normal increases of haemoglobin and haematocrit values.
WhAT Are The poTenTiAl ConCerns of 
geoloCAlisATion of AThleTes?
privacy and data security
The implementation of the whereabouts system has led to 
discussions about whether this system is an infringement of an 
athlete’s right to privacy.2 Athletes have a moral and legal right 
to privacy and, as such, this raises questions about when it would 
be appropriate for antidoping agencies to access information 
about athletes’ whereabouts.3 The principle of proportionality 
plays an important role in this evaluation, as whereabouts rules 
should pursue a legitimate aim (eg, antidoping) but should not 
interfere unnecessarily with an individual’s rights and interests.12 
Despite existing critiques on the whereabouts system, the current 
approach is increasingly accepted as ‘an imperfect, but still 
largely useful and moderately successful deterrent and detection 
system for otherwise virtually undetectable doping methods’.13
Subjecting athletes to reporting their whereabouts is already 
an exceptional measure that can only be legitimised by its aim 
(antidoping) and means (its voluntary character). With regard 
to the latter, athletes may withdraw from surveillance if they 
quit elite sport, they are aware of the sanctions and the system 
is transparent.5
The current whereabouts information of athletes is available 
through ADAMS to WADA and other ADOs with the authority 
box 1 in light of this debate, the WAdA ethics panel 
formulated the following questions
1. Should WADA and/or other sponsors consider funding such 
geolocalisation research projects?
2. If successful, could they be proposed to athletes as a 
complementary device to Anti-Doping Administration and 
Management System to help geolocalisation and reduce the 
risk of missed tests?
3. Should such devices be offered on a voluntary basis, or is 
it conceivable that they would be made mandatory for all 
athletes in registered testing pools?
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to test athletes. Only authorised persons can access this plat-
form and use it exclusively for doping control purposes.12 It can 
be argued that geolocalisation could fit in the current where-
abouts framework. Indeed, location-based information could be 
restricted to authorised persons with the use of filters that would 
only give access to specific time frames (eg, not at night and only 
during the predetermined 60 min time slot). However, it should 
be considered that various athletes already perceive the current 
whereabouts system as privacy infringing and that adding geolo-
calisation would only increase this feeling. Moreover, according 
to one study, only a minority of athletes support such devices.6
In addition, from a data security perspective, the collec-
tion of ongoing location information from an identified indi-
vidual should be considered highly sensitive data. This creates 
important considerations for the level of data storage and access. 
Data breaches would be highly problematic. The recent Fancy 
Bears data hacking shows that such concerns are certainly rele-
vant. Athletes might fear that their data could be hacked, leading 
to a potentially negative impact on their career.14 Moreover, 
concerns exist about software that allows editing existing data 
points and the creation of false location profiles.15 Of course, 
there are already privacy risks in the current whereabouts 
system, and the degree to what extent geolocalisation could be 
considered intrusive would depend on the way and the amount 
of localisation  data that is being collected.
Considering the above-mentioned concerns related to the 
use of such technologies, the likelihood of increased harm in 
the trust and reputation of antidoping agencies and WADA is 
bigger than the potential benefits from use of such technology. 
Even under a voluntary scheme in which athletes could opt in 
for using a location-tracking technology, potential abuse of such 
information is foreseeable. Athletes could be pressured directly 
or indirectly to use such technologies by employers, trainers or 
sponsors.
The use of geolocalisation has also wider societal ramifica-
tions. The use of surveillance in one context might also increase 
the use in other contexts. Of particular concern is a further use 
of location information of athletes by employers, trainers and 
sponsors and in the management of athletes. Although it might 
be of interest to monitor training schemes or activities, it would 
increase the degree of constant surveillance and monitoring of 
athletes and breach rights to privacy.3 Also in these contexts, the 
potential advantages of such an approach should be balanced 
with attention to autonomy and privacy considerations, as well 
as considerations regarding further (inappropriate) use of such 
data.
pragmatic considerations
In addition to the various concerns noted, various practical 
reasons undermine the capacity for location-based devices to 
replace the existing whereabouts systems. Indeed, in order to 
allow antidoping officials to plan antidoping controls outside 
competitions, athletes would still be required to submit their 
planned locations in ADAMS, as location-based devices only 
identify individuals at a given point in time and not in the 
future. Moreover, GPS tracking can provide inaccuracies in 
dense forests or between tall buildings or could be affected 
by other system failures.15 Athletes could also forget, lose or 
break their tracking devices (accidentally or otherwise), which 
would present serious difficulties for strict liability on which 
antidoping policy exists.16 Cheating athletes could give their 
phones or tracking devices to individuals in their environment. 
It questions also whether a ‘disappearance’ off the grid would 
potentially lead to a whereabouts failure. Therefore, the ques-
tion is precisely what kind of benefit a location-based device 
could provide compared with calling an athlete on a cellphone 
in case the athlete cannot be found within the disclosed location 
during the 60 min time slot. Moreover, such a location-tracking 
device would not be able to replace any other witness in order to 
testify that an athlete was at a certain place, if such evidence was 
needed within the framework of an antidoping procedure. Yet, 
we would argue that the use of geolocalisation wouldn’t resolve 
some of the administrative and pragmatic concerns related to the 
current antidoping procedures.
ConClusion
Through the widespread availability of location-identifying 
devices, geolocalisation could potentially be used to place 
athletes during out-of-competition testing. We conclude:
should WAdA and/or other sponsors consider funding such 
geolocalisation research projects?
The use of geolocalisation could be useful in a research setting 
with the goal of understanding associations between genotype, 
phenotype and environment. In particular, knowledge of the 
effect of altitude exposure on athletes would be useful. This 
should be possible within a controlled environment, in which 
a research proposal was developed and approved by an insti-
tutional review board or research ethics committees and in a 
situation where individuals are recruited through an informed 
consent process outside an antidoping context. Also in this 
context, privacy issues should be considered in the research 
protocol. However, such research projects should not be focused 
on developing tools to be used in a whereabouts system.
if successful, could they be proposed to athletes as a 
complementary device to AdAms to help geolocalisation and 
reduce the risk of missed tests?
The use of geolocalisation as part of or as replacement of 
whereabouts rules is, however, burdened by significant ethical 
concerns. While benefits remain largely hypothetical and 
minimal, the potential invasion of privacy and the data security 
threats are real. Currently, it seems likely that the technology 
could result in more harm than benefit to athletes, the sport and 
the antidoping movement.
should such devices be offered on a voluntary basis, or is 
it conceivable that they would be made mandatory for all 
athletes in rTps?
Considering the impact on privacy, data security issues, the soci-
etal ramifications of offering such services and various other 
pragmatic considerations, the WADA Ethics Panel concludes that 
at this time, the use of geolocalisation is not justified. It should 
neither be mandated as a tool for disclosing whereabouts nor 
implemented on a voluntary basis.
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